INVESTMENT
The CDTI Innovation, through Innvierte, approves 24 new co-investments and participate in 6 investment vehicles, with a commitment of about 323 million euros
The investment commitment by CDTI Innovation in the last four months is about 323 million euros
Ver sección
The CDTI SICC Innvierte of Innovation invests together with Bullnet Capital in 2EyesVision, innovative company ophthalmic technology
The contribution of CDTI committed Innovation in this endeavour is a total of eur 3 million
Ver sección
The CDTI SICC Innvierte of investing in Innovation Ingelia, together with two coinversores, to develop a technology to manage any residues biomass hydrochar, producing a sustainable and high-quality
The contribution of CDTI Innovation in this endeavour is a total of €2.718.000
Ver sección
The CDTI SICC Innvierte of investing in Innovation ARTHEx Biotech, together with Invivo Ventures, F.C.R. and Columbus Life Sciences Fund III, F.C.R., to develop a new treatment of RNA for myotonic dystrophy
The CDTI Innovation brings in this operation over eur 4 million
Ver sección
The CDTI SICC Innvierte of investing in Innovation, along with Nanoligent INVEREADY BIOTECH IV PARALLEL, SCR, S.A. and INVEREADY BIOTECH IV, SCR S.A., in order to develop an oncological nanofármaco
The contribution of CDTI innovation in this operation is eur 3.6 million
Ver sección
The CDTI SICC Innvierte of investing in Innovation KIBO VENTURES FUND IV INNVIERTE, F.C.R.E., fund focused on business cyber DeepTech as artificial intelligence, robotics, climate, health, education and other disruptive technologies
The CDTI innovation has committed an investment of up to eur 73.5 million in the fund
Ver sección
The CDTI SICC Innvierte of Innovation invests in SC NET ZERO VENTURES FUND I, F.C.R.E., fund focused on climate technologies that drive the decarbonisation of industry, energy transition and mobility in europe
The CDTI innovation has committed an investment of up to €20 million in the fund
Ver sección
The CDTI SICC Innvierte of investing in Innovation 4FOUNDERS CAPITAL FUND III, F.C.R.E., fund focused on technology startups B2B models use SaaS and strong ai
The CDTI innovation has committed an investment of up to 14.75 million euros in the fund
Ver sección
The CDTI SICC Innvierte of investing in Innovation Ona Pharmaceuticals, together with five coinversores, to develop new innovative therapies using ADCs that attack cancer advanced
The contribution of CDTI innovation in this operation is eur 10 million
Ver sección
Subscribe to INVESTMENT